Our data suggests the diagnosis of IGHD should be established based on a combination of clinical expertise, auxologic, radiologic, and laboratorial data, using IGF-1 at the −2SD threshold combined with ITT or CT at the cut-off point of 7 μg/L. This evidence concerns the gene IGF1 and isolated congenital growth hormone deficiency.